"Prime Boost" Vaccination Strategy Combining Conjugated Anti- Pneumococcal Vaccine (s0) and Polysaccharide Anti- Pneumococcal Vaccine (s4) Compared to Polysaccharide Anti- Pneumococcal Vaccine Alone (s4) In Patients With Common Variable Immunodeficiency

NCT01489618 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

45

Enrollment

OTHER_GOV

Sponsor class

Stopped End of production

Conditions

Common Variable Immunodeficiency

Interventions

BIOLOGICAL: PPS
BIOLOGICAL: PnCJ PPS

Sponsor

Institut National de la Santé Et de la Recherche Médicale, France